Any publicly discussed or revealed information should be recorded and shared via the CYP website. This announcement should have been made in time to give people the opportunity to decide to travel to attend.Poster:
I note, they have also included CDI iMSCs.
To provide the answer to one of my questions posed
here:
Q: When will FCDI be ready to supply us with Cymerus MSCs for our further pre-clinical and clinical development?Initially, Waisman was meant to supply the cells for FujiFilm's P2 trial in GvHD in the US.Given the changes and delay, is FCDI now ready to supply us with the cells for our P2 GvHD trial in the US?A: FCDI have manufactured cells as part of the technology transfer, however, Waisman will still be providing the cells for our upcoming P2 GvHD trial in the US.
I followed up on your question regarding the shelf life, pointing at the
MST Access report dated 11 June 2021, " Once produced, these cells are cryogenically preserved until required and can be stored for a minimum current validated shelf life of 2 years, although Cynata is working on extending this."
At the end of the Q&A they mentioned that they have received another question and that they will address it afterwards (which was my follow-up question).
Answer:
"Shelf life is 4 years. It was once 2 years but we have obviously worked to extend."
(20min delay)